Proposed Data Collection Submitted for Public Comment and Recommendations, 3139-3140 [2016-00939]

Download as PDF 3139 Federal Register / Vol. 81, No. 12 / Wednesday, January 20, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Public Health Laboratories ..................... Public Health Laboratories ..................... Public Health Laboratories ..................... Biennial Requalification ......................... General Surveillance Testing Results ... Proficiency Testing/Validation Testing Results. Surge Event Testing Results ................ Public Health Laboratories ..................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–00955 Filed 1–19–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. [60Day–16–1074; Docket No. CDC–2016– 0006] FOR FURTHER INFORMATION CONTACT: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the information collection project entitled ‘‘Colorectal Cancer Control Program CRCCP) Monitoring Activities’’. CDC is requesting a reinstatement with change of OMB No. 0920–1074 to include a redesigned survey and a new clinic-level data collection. DATES: Written comments must be received on or before March 21, 2016. ADDRESSES: You may submit comments, identified by Docket No. CDC–2016– 0006 by any of the following methods: Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments. Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and tkelley on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:12 Jan 19, 2016 Jkt 238001 To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 1 25 5 2 24 56 150 Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. AGENCY: Average burden per response (hours) 150 150 150 Centers for Disease Control and Prevention Proposed Data Collection Submitted for Public Comment and Recommendations Average number of responses per respondent 625 24 burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Colorectal Cancer Control Program (CRCCP) Monitoring Activities—(OMB No. 0920–1074, exp. 12/31/2015)— Reinstatement with Change—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is requesting a reinstatement with change of the information collection with the OMB Control number 0920–1074, formerly entitled ‘‘Annual Survey of Colorectal Cancer Control Activities Conducted by States and Tribal Organizations.’’ In the previous OMB approval period, information collection consisted of an annual grantee survey. In the next OMB approval period, information collection will consist of a redesigned survey and a new clinic-level data collection. The number of respondents will increase and the total estimated annualized burden will increase. Among cancers that affect both men and women, colorectal cancer (CRC) is E:\FR\FM\20JAN1.SGM 20JAN1 3140 Federal Register / Vol. 81, No. 12 / Wednesday, January 20, 2016 / Notices the second leading cause of death from cancer in the United States. CRC screening has been shown to reduce incidence of and death from the disease. Screening for CRC can detect disease early when treatment is more effective and prevent cancer by finding and removing precancerous polyps. Of individuals diagnosed with early stage CRC, more than 90% live five or more years. Despite strong evidence supporting screening, only 65% of adults currently report being up-to-date with CRC screening as recommended by the U.S. Preventive Services Task Force, with more than 22 million age-eligible adults estimated to be untested. To reduce CRC morbidity, mortality, and associated costs, use of CRC screening tests must be increased among ageeligible adults with the lowest CRC screening rates. CDC’s Colorectal Cancer Control Program (CRCCP) currently provides funding to 31 grantees under ‘‘Organized Approaches to Increase Colorectal Cancer Screening’’ (CDC– RFA–DP15–1502). CRCCP grantees include state governments or bona-fide agents, universities, and tribal organizations. The purpose of the new cooperative agreement program is to RFA–DP15–1502) requires that CDC monitor and evaluate the CRCCP and individual grantee performance using both process and outcome evaluation. Two forms of data collection are proposed. First, the CRCCP grantee survey was redesigned to align with new CRCCP goals. The grantee survey will be submitted to CDC annually. Second, CDC proposes to collect cliniclevel data to assess changes in CDC’s primary outcome of interest, i.e., CRC screening rates within partner health systems. Each grantee will complete a clinic-level data template once per month. All information will be reported to CDC electronically. The information collection will enable CDC to gauge progress in meeting CRCCP program goals and to monitor implementation activities, evaluate outcomes, and identify grantee technical assistance needs. In addition, findings will inform program improvement and help identify successful activities that need to be maintained, replicated, or expanded. OMB approval is requested for three years. Participation is required for CRCCP awardees. There are no costs to respondents other than their time. increase CRC screening rates among an applicant defined target population of persons 50–75 years of age within a partner health system serving a defined geographical area or disparate population. The CRCCP was significantly redesigned in 2015 and has two components. Under Component 1, all 31 CRCCP grantees receive funding to support partnerships with health systems to implement up to four priority evidence-based interventions (EBIs) described in the Guide to Community Preventive Services, as well as other supporting strategies. Grantees must implement at least two EBIs in each partnering health system. Under Component 2, 6 of the 31 CRCCP grantees will provide direct screening and follow-up clinical services for a limited number of individuals aged 50– 64 in the program’s priority population who are asymptomatic, at average risk for CRC, have inadequate or no health insurance for CRC screening, and are low income Based on the redesigned CRCCP, the information collection plan has also been redesigned to address the two program components. The new cooperative agreement program (CDC– ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hr) Total burden (in hr) Type of respondent Form name CRCCP Grantees ......................................... CRCCP Annual Grantee Survey. CRCCP Clinic-level Data Collection Template. 31 1 45/60 23 31 12 30/60 186 ............................................... ........................ ........................ ........................ 209 Total ....................................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–00939 Filed 1–19–16; 8:45 am] [60 Day–16–1061; Docket No. CDC–2016– 0008] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. tkelley on DSK4VPTVN1PROD with NOTICES AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the SUMMARY: VerDate Sep<11>2014 18:12 Jan 19, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Behavioral Risk Factor Surveillance System (BRFSS), a statelevel survey of health risk behaviors and chronic health conditions. Survey questions are updated each year. The information collection is being revised to incorporate an annual field test of proposed changes prior to their implementation on a broad scale. Written comments must be received on or before March 21, 2016. DATES: You may submit comments, identified by Docket No. CDC–2016– 0008 by any of the following methods: ADDRESSES: E:\FR\FM\20JAN1.SGM 20JAN1

Agencies

[Federal Register Volume 81, Number 12 (Wednesday, January 20, 2016)]
[Notices]
[Pages 3139-3140]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00939]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-16-1074; Docket No. CDC-2016-0006]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the information 
collection project entitled ``Colorectal Cancer Control Program CRCCP) 
Monitoring Activities''. CDC is requesting a reinstatement with change 
of OMB No. 0920-1074 to include a redesigned survey and a new clinic-
level data collection.

DATES: Written comments must be received on or before March 21, 2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0006 by any of the following methods:
    Federal eRulemaking Portal: Regulation.gov. Follow the instructions 
for submitting comments.
    Mail: Leroy A. Richardson, Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Colorectal Cancer Control Program (CRCCP) Monitoring Activities--
(OMB No. 0920-1074, exp. 12/31/2015)--Reinstatement with Change--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a reinstatement with change of the information 
collection with the OMB Control number 0920-1074, formerly entitled 
``Annual Survey of Colorectal Cancer Control Activities Conducted by 
States and Tribal Organizations.'' In the previous OMB approval period, 
information collection consisted of an annual grantee survey. In the 
next OMB approval period, information collection will consist of a 
redesigned survey and a new clinic-level data collection. The number of 
respondents will increase and the total estimated annualized burden 
will increase.
    Among cancers that affect both men and women, colorectal cancer 
(CRC) is

[[Page 3140]]

the second leading cause of death from cancer in the United States. CRC 
screening has been shown to reduce incidence of and death from the 
disease. Screening for CRC can detect disease early when treatment is 
more effective and prevent cancer by finding and removing precancerous 
polyps. Of individuals diagnosed with early stage CRC, more than 90% 
live five or more years. Despite strong evidence supporting screening, 
only 65% of adults currently report being up-to-date with CRC screening 
as recommended by the U.S. Preventive Services Task Force, with more 
than 22 million age-eligible adults estimated to be untested. To reduce 
CRC morbidity, mortality, and associated costs, use of CRC screening 
tests must be increased among age-eligible adults with the lowest CRC 
screening rates.
    CDC's Colorectal Cancer Control Program (CRCCP) currently provides 
funding to 31 grantees under ``Organized Approaches to Increase 
Colorectal Cancer Screening'' (CDC-RFA-DP15-1502). CRCCP grantees 
include state governments or bona-fide agents, universities, and tribal 
organizations. The purpose of the new cooperative agreement program is 
to increase CRC screening rates among an applicant defined target 
population of persons 50-75 years of age within a partner health system 
serving a defined geographical area or disparate population.
    The CRCCP was significantly redesigned in 2015 and has two 
components. Under Component 1, all 31 CRCCP grantees receive funding to 
support partnerships with health systems to implement up to four 
priority evidence-based interventions (EBIs) described in the Guide to 
Community Preventive Services, as well as other supporting strategies. 
Grantees must implement at least two EBIs in each partnering health 
system. Under Component 2, 6 of the 31 CRCCP grantees will provide 
direct screening and follow-up clinical services for a limited number 
of individuals aged 50-64 in the program's priority population who are 
asymptomatic, at average risk for CRC, have inadequate or no health 
insurance for CRC screening, and are low income
    Based on the redesigned CRCCP, the information collection plan has 
also been redesigned to address the two program components. The new 
cooperative agreement program (CDC-RFA-DP15-1502) requires that CDC 
monitor and evaluate the CRCCP and individual grantee performance using 
both process and outcome evaluation. Two forms of data collection are 
proposed. First, the CRCCP grantee survey was redesigned to align with 
new CRCCP goals. The grantee survey will be submitted to CDC annually. 
Second, CDC proposes to collect clinic-level data to assess changes in 
CDC's primary outcome of interest, i.e., CRC screening rates within 
partner health systems. Each grantee will complete a clinic-level data 
template once per month. All information will be reported to CDC 
electronically.
    The information collection will enable CDC to gauge progress in 
meeting CRCCP program goals and to monitor implementation activities, 
evaluate outcomes, and identify grantee technical assistance needs. In 
addition, findings will inform program improvement and help identify 
successful activities that need to be maintained, replicated, or 
expanded.
    OMB approval is requested for three years. Participation is 
required for CRCCP awardees. There are no costs to respondents other 
than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent        (in hr)         (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees................  CRCCP Annual                  31               1           45/60              23
                                 Grantee Survey.
                                CRCCP Clinic-                 31              12           30/60             186
                                 level Data
                                 Collection
                                 Template.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             209
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-00939 Filed 1-19-16; 8:45 am]
BILLING CODE 4163-18-P